Nathan Constantine‐Cooke

Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naïve SB5 Observational Cohorts

L Derikx, Heather W Dolby, Nikolas Plevris et al. · Journal of Crohn s and Colitis · 2021 · 32 citations · Full text

Real-world effectiveness of upadacitinib in Crohn’s disease: a UK multicentre retrospective cohort study

Alexander T. Elford, Maria Bishara, Nikolas Plevris et al. · Frontline Gastroenterology · 2024 · 27 citations · Full text

Real-world Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative Colitis

Beatriz Gros, Mairi Goodall, Nikolas Plevris et al. · Journal of Crohn s and Colitis · 2023 · 26 citations · Full text

Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort

Beatriz Gros, Nikolas Plevris, Nathan Constantine‐Cooke et al. · United European Gastroenterology Journal · 2023 · 17 citations · Full text

Longitudinal Fecal Calprotectin Profiles Characterize Disease Course Heterogeneity in Crohn’s Disease

Nathan Constantine‐Cooke, Karla Monterrubio‐Gómez, Nikolas Plevris et al. · Clinical Gastroenterology and Hepatology · 2023 · 14 citations · Full text